GH may reduce the liver damage caused by BD before graft retrieval through the upregulation of both VEGFB and VEGFA in the intestine, whereas only VEGFA is feasible to reduce liver damage in DBDs with ALD after CI/R in experimental models of ex vivo and in vivo LT (Figure 5). The gene discussed is VEGFA; the disease is Behcet disease.